Capital Fund Management (CFM)
ECYT

Capital Fund Management (CFM)’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Capital Fund Management (CFM)’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-29,435
Closed -$153K – 1776
2015
Q2 		$153K Buy
+29,435
New +$177K ﹤0.01% 1411

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Fund Management (CFM)'s ECYT Position: Q3 2015 in Review

Capital Fund Management (CFM) sold out of Endocyte, Inc. Common Stock (ECYT) in Q3 2015, closing a stake of 29,435 shares — an estimated $153K sold.

Capital Fund Management (CFM) first reported a position in ECYT in Q2 2015 and held it in 1 quarter. The position peaked at $153K in Q2 2015. 104 funds tracked by Wall St. Rank hold ECYT as of Q3 2015.

  • Capital Fund Management (CFM) reported no remaining Endocyte, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 29,435 Endocyte, Inc. Common Stock shares in Q3 2015, an estimated $153K.
  • Capital Fund Management (CFM) first reported a position in Endocyte, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
  • Capital Fund Management (CFM)'s Endocyte, Inc. Common Stock position peaked at $153K in Q2 2015.
  • 104 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q3 2015.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2015, filed 27 Oct 2015.